LUXTURNA conc inj c solv
7680673710012
CH-67371
S01XA27
Reimbursement limitations:
LUXTURNA
Après la garantie de la prise en charge de l’assurance maladie et la consultation préalable …
1 / 3
google
Details
- Product number
- 6737101
- CPT
- -
- Packaging group
- -
- Unit
- Beutel
- Composition
- voretigenum neparvovecum 5 x 10e12 vector genomes/mL, natrii dihydrogenophosphas monohydricus, dinatrii phosphas dihydricus, poloxamerum 188, natrii chloridum, aqua ad iniectabile, q.s. pro praeparatione.
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
- | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 327657.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2021
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 67371
- Drug name
- Luxturna, Konzentrat und Lösungsmittel zur Herstellung einer Injektionslösung
- Galenic form
- LSPA
- ATC Code
- S01XA27
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 14/02/2020
- Authorization expiration date
- 31/12/9999
- Domain
- Human medicine
Packaging details
- Description (FR)
- LUXTURNA conc inj c solv
- Description (DE)
- LUXTURNA Inj Konz c Solv
- Market launch
- 14/02/2020
- Narcotic (BTM)
- No
Application methods
IOCUL